XMH:CA:TSX-iShares S&P US Mid-Cap CAD Hedged (CAD)

ETF | US Small/Mid Cap Equity |

Last Closing

CAD 27.92

Change

-0.13 (-0.46)%

Market Cap

CAD 0.24B

Volume

1.69K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for US Small/Mid Cap Equity

Symbol Name Price(Change) Market Cap
XSU:CA iShares US Small Cap (CAD Hedg..

+0.04 (+0.09%)

CAD 0.73B
XSU:CA iShares US Small Cap (CAD Hedg..

+0.04 (+0.09%)

CAD 0.73B
XMC:CA iShares S&P US Mid-Cap

+0.06 (+0.19%)

CAD 0.33B
XMC:CA iShares S&P US Mid-Cap

+0.06 (+0.19%)

CAD 0.33B
DXZ:CA Dynamic Active U.S. Mid-Cap ET..

-0.06 (-0.45%)

CAD 0.03B
DXZ:CA Dynamic Active U.S. Mid-Cap ET..

-0.06 (-0.45%)

CAD 0.03B
UMI:CA CI U.S. MidCap Dividend Index ..

N/A

CAD 0.02B
UMI:CA CI U.S. MidCap Dividend Index ..

N/A

CAD 0.02B
MUMC:CA Manulife Multifactor U.S. Mid ..

+0.11 (+0.25%)

CAD 8.94M
MUMC:CA Manulife Multifactor U.S. Mid ..

+0.11 (+0.25%)

CAD 8.94M

ETFs Containing XMH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Small/Mid Cap Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.32% 36% F 49% F
Dividend Return 0.43% 83% B 14% F
Total Return 11.75% 36% F 46% F
Trailing 12 Months  
Capital Gain 24.48% 21% F 66% D+
Dividend Return 1.25% 83% B 27% F
Total Return 25.73% 50% F 61% D-
Trailing 5 Years  
Capital Gain 55.02% 58% F 71% C-
Dividend Return 5.73% 50% F 19% F
Total Return 60.76% 75% C 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.96% N/A N/A 76% C+
Dividend Return 12.97% N/A N/A 73% C
Total Return 1.01% N/A N/A 36% F
Risk Return Profile  
Volatility (Standard Deviation) 22.98% N/A N/A 65% D
Risk Adjusted Return 56.46% N/A N/A 73% C
Market Capitalization 0.24B 64% D 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.